Review
doi: 10.1002/1520-7560(200009/10)16:1+<::aid-dmrr142>3.0.co;2-s.
New treatments in ulcer healing and wound infection
Affiliations
- PMID: 11054889
- DOI: 10.1002/1520-7560(200009/10)16:1+<::aid-dmrr142>3.0.co;2-s
Item in Clipboard
Review
New treatments in ulcer healing and wound infection
Diabetes Metab Res Rev.
2000 Sep-Oct.
Abstract
This review examines several of the recently introduced wound care products that have been put forward as treatment modalities for the diabetic foot ulcer. Discussed are the results of clinical trials with the platelet-derived growth factor, becaplermin, the tissue-engineered products Dermagraft and Apligraf, and Hyaff which is an ester of hyaluronic acid. In patients with an infected foot ulcer, encouraging results were obtained with the granulocyte-colony stimulating factor, Filgrastim.
Copyright 2000 John Wiley & Sons, Ltd.
Similar articles
-
[New developments in the treatment of diabetic foot ulcers].Ned Tijdschr Geneeskd. 2000 Feb 26;144(9):409-12. Ned Tijdschr Geneeskd. 2000. PMID: 10719543 Review. Dutch.
-
Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers.BMC Health Serv Res. 2009 Jul 10;9:115. doi: 10.1186/1472-6963-9-115. BMC Health Serv Res. 2009. PMID: 19591680 Free PMC article. Review.
-
Advanced biological therapies for diabetic foot ulcers.Arch Dermatol. 2010 Aug;146(8):857-62. doi: 10.1001/archdermatol.2010.164. Arch Dermatol. 2010. PMID: 20713816
-
The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data.Value Health. 2000 Nov-Dec;3 Suppl 1:39-46. doi: 10.1046/j.1524-4733.2000.36027.x. Value Health. 2000. PMID: 16464208 Clinical Trial.
-
Cost-effective management of recalcitrant diabetic foot ulcers.Clin Podiatr Med Surg. 2002 Oct;19(4):483-91. doi: 10.1016/s0891-8422(02)00018-6. Clin Podiatr Med Surg. 2002. PMID: 12471856 Review.
Cited by
-
Role of platelet-derived growth factors in physiology and medicine.Genes Dev. 2008 May 15;22(10):1276-312. doi: 10.1101/gad.1653708. Genes Dev. 2008. PMID: 18483217 Free PMC article. Review.
-
Optimising antimicrobial therapy in diabetic foot infections.Drugs. 2007;67(2):195-214. doi: 10.2165/00003495-200767020-00003. Drugs. 2007. PMID: 17284084 Review.
-
Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse.Diabetologia. 2003 Apr;46(4):546-55. doi: 10.1007/s00125-003-1064-1. Epub 2003 Apr 2. Diabetologia. 2003. PMID: 12677400
-
Skin substitutes: a brief review of types and clinical applications.Oman Med J. 2009 Jan;24(1):4-6. doi: 10.5001/omj.2009.2. Oman Med J. 2009. PMID: 22303500 Free PMC article.
-
Associated risk factors and management of chronic diabetic foot ulcers exceeding 6 months' duration.Diabet Foot Ankle. 2012;3. doi: 10.3402/dfa.v3i0.18980. Epub 2012 Oct 30. Diabet Foot Ankle. 2012. PMID: 23119125 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
